Roche won emergency approval from the FDA for a highly automated coronavirus test, potentially speeding up tenfold the ability to test patients.
The test runs on Roche’s cobas 6800/8800 systems and is also available in Europe and countries that accept its CE marking for medical devices.
The 8800 version is capable of testing 4,128 patients a day, and the 6800 can test as many as 1,440. Roche shares climbed early Friday as a result.
Read the full article at Bloomberg.com…
Your email address will not be published. Required fields are marked *
Drug pricing remains a hot topic, and a new report from GoodRx ranking the country’s 20 costliest drugs shows that...